Apollo Hospitals Enterprise Limited — PPTs, 10-02-2026: Investor Presentation

Apollo Hospitals posted robust financial results for the latest quarter. Consolidated revenue jumped 17% YoY to ₹6,477.4 Cr, with EBITDA up 27% to ₹965.3 Cr, and profit (PAT) surging 35% to ₹502.3 Cr.

Healthcare Services revenue grew 14%, fueled by a 4% rise in inpatient volumes and an 11% increase in average revenue per patient. Diagnostics & Retail Health (AHLL) saw revenue climb 20%, with EBITDA up 39%, largely from diagnostics expansion. Apollo HealthCo (Digital & Pharmacy) revenue also grew 20%, significantly reducing its digital cash loss to ₹29.2 Cr as platform GMV surged 28% to ₹525 Cr.

Strategically, Apollo plans to add ~3,600 census beds across Healthcare Services over the next five years, involving a ₹8,200 Cr investment. Recent developments include advanced gene therapy and robotic surgery centers. HealthCo is set for a listing by Q4 FY27, targeting an annualized revenue run rate of ₹25,000 Cr with a 7% EBITDA margin.